Pricing Log in Create free account

Impact Biomedical Inc. (IBO) vs Pelthos Therapeutics Inc. (PTHS)

Impact Biomedical Inc. and Pelthos Therapeutics Inc. are both Biotechnology companies. Impact Biomedical Inc. and Pelthos Therapeutics Inc. are of similar size ($38.0M and $35.6M). Impact Biomedical Inc. has the higher net margin (2,254.3% vs −199.5%) and the higher return on invested capital (−22.8% vs −82.3%). Across the 15 metrics below, Pelthos Therapeutics Inc. leads on 9 and Impact Biomedical Inc. on 6.

Valuation

Metric IBO PTHS Biotechnology median
P/E n/m n/m 10.60
P/S 1,000.83 0.78 9.40
P/B 2.50 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1,228.29 1.88 9.02
Earnings yield (27.13%) (276.23%) (32.88%)
Free cash flow yield (1.50%) (126.55%) (23.13%)

Profitability

Metric IBO PTHS Biotechnology median
Gross margin (1,111.43%) 78.59% 68.51%
Operating margin (14,600.00%) (133.42%) 0.00%
Net margin 2,254.29% (199.50%) 0.00%
Free cash flow margin (1,451.43%) (98.37%) 0.00%
Return on equity 24.01% 2,161.07% (51.96%)
Return on assets 4.41% (125.04%) (46.06%)
Return on invested capital (22.81%) (82.34%) 0.00%

Growth

Metric IBO PTHS Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 83.48% (61.12%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric IBO PTHS Biotechnology median
Debt to equity 0.00 (46.58) 0.00
Current ratio 0.16 1.98 4.97
Net debt to EBITDA 0.00 (0.45) 1.01

Dividend

Metric IBO PTHS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IBO PTHS Biotechnology median
Market cap 38.01m 35.61m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack